Research Topics
| Selim M ArcasoySummaryAffiliation: Columbia University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Medical complications after lung transplantationSelim M Arcasoy
Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Semin Respir Crit Care Med 27:508-20. 2006..This article reviews the most frequent and important medical complications of lung transplantation, other than rejection and infection, with an emphasis on complications that involve the respiratory tract...- Medical complications and management of lung transplant recipientsSelim M Arcasoy
Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, New York, NY, USA
Respir Care Clin N Am 10:505-29. 2004..Close and parallel attention to pulmonary and nonpulmonary medical complications and management of lung transplant recipients by a multidisciplinary team are the most important ingredients of optimal long-term outcomes... - Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomesSelim M Arcasoy
Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
J Heart Lung Transplant 24:1483-8. 2005 - Local and systemic thrombolytic therapy for acute venous thromboembolismSelim M Arcasoy
Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, Lung Transplantation Program, New York Presbyterian Hospital of Columbia, Cornell University, New York, NY 10032, USA
Clin Chest Med 24:73-91. 2003.... - Echocardiographic assessment of pulmonary hypertension in patients with advanced lung diseaseSelim M Arcasoy
Division of Pulmonary, Allergy and Critical Care, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Am J Respir Crit Care Med 167:735-40. 2003.... 
Racial differences in waiting list outcomes in chronic obstructive pulmonary diseaseDavid J Lederer
Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, 622 West 168th Street, PH 8, Room 101, New York, NY 10032, USA
Am J Respir Crit Care Med 177:450-4. 2008..Blacks with chronic illness have poorer outcomes than whites in the United States. The health outcomes of minorities with chronic obstructive pulmonary disease (COPD) on the lung transplant waiting list have not been studied...
Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort studyMuhammet R Celik
Department of Surgery, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York
J Heart Lung Transplant 28:697-703. 2009..The efficacy and safety of different combinations of immunosuppressive regimens after lung transplantation are unknown...- The modification of diet in renal disease (MDRD) and the prediction of kidney outcomes after lung transplantationNadine Al-Naamani
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA
J Heart Lung Transplant 27:1191-7. 2008.... - Platelet activation in the postoperative period after lung transplantationDavid I Sternberg
Lung Transplant Program, Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
J Thorac Cardiovasc Surg 135:679-84. 2008..The platelet response to the pulmonary allograft, however, has never been studied. Here we report significant platelet activation immediately after lung transplantation... - Obesity and underweight are associated with an increased risk of death after lung transplantationDavid J Lederer
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
Am J Respir Crit Care Med 180:887-95. 2009..Obesity is considered a relative contraindication to lung transplantation, based on studies that have not accounted for key confounders. Little is known about the risk of death for underweight candidates after transplantation... - Risk factors for venous thromboembolism after lung transplantationHilary A Yegen
Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Chest 132:547-53. 2007..The risk factors for venous thromboembolism (VTE) following lung transplantation are not well established. We aimed to estimate the incidence of VTE and to identify the risk factors for VTE after lung transplantation... - Outcomes after lung retransplantation in the modern eraSteven M Kawut
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Am J Respir Crit Care Med 177:114-20. 2008..Characteristics of and survival estimates for recipients of lung retransplantation in the modern era are unknown... - Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity StudyDavid J Lederer
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
Am J Respir Crit Care Med 184:1055-61. 2011..Obesity has been linked to acute lung injury and is a risk factor for early mortality after lung transplantation... - Immunoglobulin G levels before and after lung transplantationNatalie H Yip
Department of Medicine ad Surgery, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
Am J Respir Crit Care Med 173:917-21. 2006..Baseline IgG levels and treatment with mycophenolate mofetil affect post-transplant IgG levels... - Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosisAdel M Assaad
Department of Pathology, Division of Surgical Pathology, 630 West 168th St, VC14 215, New York, NY 10032, USA
Chest 131:850-5. 2007..Pulmonary capillary hemangiomatosis (PCH) is a rare cause of pulmonary arterial hypertension with no effective medical therapy and a high risk of mortality. The pathogenesis of PCH is unknown... - Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosisDavid J Lederer
Department of Medicine, College of Physicians and Surgeons, Joseph L. Mailman School of Public Health, Columbia University, New York, New York 10032, USA
Am J Respir Crit Care Med 174:659-64. 2006..02). CONCLUSIONS: Lower 6MWD was strongly and independently associated with an increased mortality rate for wait-listed patients classified as having IPF. 6MWD was a better predictor of death at 6 mo than was FVC % predicted... - Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantationSteven M Kawut
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
Respir Med 99:1431-9. 2005..We hypothesized that cardiopulmonary exercise test results and the distance walked in 6min (6MWTD) would be associated with survival in patients with diffuse parenchymal lung disease referred for lung transplantation... - Evaluation of pulmonary function and exercise performance by cardiopulmonary exercise testing before and after lung transplantationMatthew N Bartels
Department of Rehabilitation and Regenerative Medicine, College of Physicians and Surgeons, Columbia University New York, NY, USA
Chest 140:1604-11. 2011..The objective of this study was to describe and compare posttransplant improvement in lung function and peak exercise parameters in patients with advanced lung disease... - Osteoporosis in diffuse parenchymal lung diseaseCaralee E Caplan-Shaw
Department of Medicine, Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, New York, NY 10032, USA
Chest 129:140-6. 2006..Given their increased risk of bone loss, patients with DPLD should undergo screening for osteoporosis and receive prophylaxis and treatment according to published guidelines... - Risk factors and outcomes of hypogammaglobulinemia after lung transplantationSteven M Kawut
Department of Medicine, College of Physicians and Surgeons, Columbia University, 622 West 168th Street, New York, NY 10032, USA
Transplantation 79:1723-6. 2005..METHODS.: The authors performed a retrospective cohort study of 57 lung transplant recipients at their center. Quantitative total and subclass immunoglobulin (Ig) G levels were obtained from patients... - Postlung transplant survival is equivalent regardless of cytomegalovirus match statusMark J Russo
Lung Transplant Program and International Center for Health Outcomes and Innovation Research, Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York, USA
Ann Thorac Surg 84:1129-34; discussion 1134-5. 2007.... - Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantationRupal J Shah
Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Transl Res 160:435-42. 2012..Persistent elevations in MCP-1 levels at 24 hours are a biomarker of grade 3 PGD post-transplantation. Monocyte chemotaxis may play a role in the pathogenesis of PGD... - Association between pulmonary fibrosis and coronary artery diseaseJorge R Kizer
Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA
Arch Intern Med 164:551-6. 2004..Further research is necessary to confirm this relationship and to explore the pathologic processes underlying, and potentially linking, these 2 conditions... - Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndromeDavid J Lederer
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
J Heart Lung Transplant 24:1697-9. 2005..Lung transplantation is a viable therapeutic option in patients with pulmonary fibrosis and only a mild bleeding diathesis associated with HPS... - Delayed access and survival in idiopathic pulmonary fibrosis: a cohort studyDaniela J Lamas
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
Am J Respir Crit Care Med 184:842-7. 2011..Idiopathic pulmonary fibrosis is often initially misdiagnosed. Delays in accessing subspecialty care could lead to worse outcomes among those with idiopathic pulmonary fibrosis... - Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantationVivek N Ahya
Division of Pulmonary, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
J Heart Lung Transplant 30:175-81. 2011..In this study, we found an increased risk of venous thromboembolism (VTE) in lung transplant recipients treated with a sirolimus (SIR)-based immunosuppressive regimen... - Update in surgical therapy for chronic obstructive pulmonary diseaseDavid J Lederer
Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, Lung Transplantation Program, PH 14 East, Room 104, New York, NY 10032, USA
Clin Chest Med 28:639-53, vii. 2007..Recent results from the National Emphysema Treatment Trial, updated International Society for Heart and Lung Transplantation Registry data, and revised guidelines for patient selection for lung transplantation are discussed... - Assessment of kidney function in lung transplant candidatesNadine Al-Naamani
Lung Transplant Program, Columbia University, New York, New York 10032, USA
J Heart Lung Transplant 27:635-41. 2008..Although creatinine-based formulas that estimate GFR have been derived, none have been validated in patients with severe lung disease... - Outcomes of extended donor lung recipients after lung transplantationSteven M Kawut
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
Transplantation 79:310-6. 2005..Many lung-transplant programs use lungs that do not meet the formal criteria for acceptability; however, the immediate and long-term consequences of this approach remain unclear... - Malignancies following lung transplantationHilary Y Robbins
Lung Transplantation Program, Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, NY 10032, USA
Clin Chest Med 32:343-55. 2011..This article addresses the epidemiology, presentation, and treatment of the most common malignancies after lung transplantation, including skin cancer, posttransplant lymphoproliferative disorder, and bronchogenic carcinoma... - Pulmonary capillary hemangiomatosis: results of gene expression analysisSteven M Kawut
Department of Medicine, College of Physicians and Surgeons, New York, NY, USA
Chest 128:575S-5766S. 2005 - Images in clinical medicine. Pulmonary alveolar proteinosisSelim M Arcasoy
Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
N Engl J Med 347:2133. 2002 - Surrogate markers and risk factors for chronic lung allograft dysfunctionMichael E Bowdish
University of Southern California, Los Angeles, CA, USA
Am J Transplant 4:1171-8. 2004.... - Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcomeWilson Y Szeto
Department of Surgery, Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
J Thorac Cardiovasc Surg 124:241-9. 2002..We hope that this pilot study removes some of the unwarranted fear of the use of bypass in lung transplantation for chronic obstructive pulmonary disease... - Clinical risk factors for primary graft failure following lung transplantationJason D Christie
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelhia, 19104, USA
Chest 124:1232-41. 2003..s: Primary graft failure (PGF) is a devastating acute lung injury syndrome following lung transplantation. We sought to identify donor, recipient, and operative risk factors for its development...